Resurgent Financial Advisors LLC Crispr Therapeutics Ag Transaction History

Resurgent Financial Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$38.62 - $72.18 $15,525 - $29,016	402 New	402 $25,000
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $17,909 - $27,921	412 New	412 $23,000
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $9,405 - $15,760	-240 Reduced 4.66%	4,912 $199,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $26,334 - $36,109	431 Added 9.13%	5,152 $336,000
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $19,496 - $33,297	451 Added 10.56%	4,721 $287,000
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $227,121 - $338,354	4,270 New	4,270 $268,000

486

57.9M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resurgent Financial Advisors LLC with notifications on news.